Viking Therapeutics, Inc. (VKTX)

37.53 +0.25 (+0.67%) USD  |  NASDAQ  |  Dec 10, 16:00
37.46 -0.07 (-0.19%) After-Hours: 20:00
More

Viking Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Altimmune, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade